Mark Hopkinson, Head of the Centre for Deaf Education, City Lit states why we need to talk more about hearing loss.
Here, we find out about the role that the National Institute of Environmental Health Sciences, a publicly-funded institute, when it comes to funding obesity research in the U.S. today.
Juliet Bouverie, Chief Executive of the Stroke Association explores the challenges around recovery from stroke.
Rachel White, Head of Public Affairs, Sustrans shares her views on how the Cycle to Work Scheme is promoting health for people and our environment.
Dr Andrew Bremer, a Paediatric Endocrinologist and Chief of the Pediatric Growth and Nutrition Branch at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the U.S. National Institutes of Health, details NICHD-supported research on vitamin D in pregnancy and early childhood development.
Hong Kong’s Elderly Health Service has an increasingly important role to play in improving primary healthcare of the elderly, as this article discovers, with a special focus on recommended exercise as one of the many elements to promote healthy ageing in individuals.
The NHS could save £300 million over the next 3 years as Phase 4 of the Electronic Prescription Service (EPS) is rolled out across the country.
Claudia Marinetti, Director of Mental Health Europe tells us why Europe needs to end coercion in mental health.
In this exclusive interview with Prof Olufunmilayo Lesi, Regional Medical Officer for Viral Hepatitis from the World Health Organization (WHO) Office for the Africa Region, discusses tackling viral hepatitis in Africa.
Here, we take a look at some recent examples of how public health in European Union Member States has been supported by the outgoing European Commissioner for Health & Food Safety, Vytenis Andriukaitis.
Steve Jones, Chair Action for Pulmonary Fibrosis and Board Member EU-IPFF and Gisli Jenkins from Nottingham University Hospitals, explain idiopathic pulmonary fibrosis (IPF), an incurable lung disease.
Sam Mountney, Senior Policy & Campaigns Officer at Epilepsy Action, shares his expertise on cannabis-based medicines as a treatment for epilepsy in the UK.
Neil Laycock, Managing Director of Healthcare, Servelec, explores the potential for digital solutions to change the narrative on managing precious assets in the healthcare environment.
Here, we look at medical devices policy of Japan’s Ministry of Health, Labour and Welfare. The Ministry now has Katsunobu Katō in place, who very recently replaced Nemoto Takumi as the Minister of Health, Labour and Welfare in the country.
The role of the Canadian Institutes of Health Research, when it comes to funding health research in Canada, is explored here, including a look at the work of the Human Development, Child and Youth Health division within that.
Cosmo Feilding Mellen, Managing Director of Spectrum Therapeutics UK looks at access to medical cannabis and to what extent is medical cannabis now legalised.
The NHS Confederation and Amnesty International respond to the Queen's Speech, highlighting elements such as a credible domestic agenda and a need for immigration reform.
For a long time the causes of acute coronary syndromes were poorly understood, and, only after the publication of our paper on New England Journal of Medicine on the importance of inflammation it was recognised as a crucial pathogenetic mechanism.
Carolyn R. Klocke and Pamela J. Lein discuss how an individual’s experiences during early life can influence their risk for disease as an adult.
Here, Cecile ten Kate discusses the process of valorisation of research projects, focusing specifically on the health innovation ecosystem.